EG19071A - Process for preparing of benzazepine and benzothiazepine derivatives - Google Patents

Process for preparing of benzazepine and benzothiazepine derivatives

Info

Publication number
EG19071A
EG19071A EG30389A EG30389A EG19071A EG 19071 A EG19071 A EG 19071A EG 30389 A EG30389 A EG 30389A EG 30389 A EG30389 A EG 30389A EG 19071 A EG19071 A EG 19071A
Authority
EG
Egypt
Prior art keywords
benzazepine
preparing
benzothiazepine derivatives
benzothiazepine
derivatives
Prior art date
Application number
EG30389A
Other languages
English (en)
Original Assignee
A R Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A R Squibb & Sons Inc filed Critical A R Squibb & Sons Inc
Application granted granted Critical
Publication of EG19071A publication Critical patent/EG19071A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
EG30389A 1988-06-20 1989-06-20 Process for preparing of benzazepine and benzothiazepine derivatives EG19071A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20852188A 1988-06-20 1988-06-20
US07/353,806 US4902684A (en) 1988-06-20 1989-05-22 Benzazepine and benzothiazepine derivatives

Publications (1)

Publication Number Publication Date
EG19071A true EG19071A (en) 1994-07-30

Family

ID=26903265

Family Applications (1)

Application Number Title Priority Date Filing Date
EG30389A EG19071A (en) 1988-06-20 1989-06-20 Process for preparing of benzazepine and benzothiazepine derivatives

Country Status (29)

Country Link
US (1) US4902684A (xx)
JP (1) JP2793674B2 (xx)
KR (1) KR970002633B1 (xx)
CN (1) CN1027262C (xx)
AT (1) AT398567B (xx)
AU (1) AU614399B2 (xx)
BE (1) BE1003305A4 (xx)
CA (1) CA1336975C (xx)
CH (1) CH681723A5 (xx)
EG (1) EG19071A (xx)
ES (1) ES2016467A6 (xx)
FI (1) FI94246C (xx)
FR (1) FR2632953B1 (xx)
GB (1) GB2231329B (xx)
GR (1) GR1002099B (xx)
HU (1) HU210929B (xx)
IE (1) IE64242B1 (xx)
IL (1) IL90515A (xx)
IT (1) IT1230884B (xx)
LU (1) LU87865A1 (xx)
NL (1) NL8920642A (xx)
NO (1) NO179449C (xx)
NZ (1) NZ229612A (xx)
PL (1) PL162313B1 (xx)
PT (1) PT90914B (xx)
RU (1) RU2090562C1 (xx)
SE (1) SE9004060L (xx)
WO (1) WO1989012633A1 (xx)
YU (1) YU121389A (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008284A (en) * 1989-02-15 1991-04-16 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4963671A (en) * 1989-11-20 1990-10-16 E. R. Squibb & Sons, Inc. Process for resolving chiral intermediates used in making calcium channel blockers
US5112969A (en) * 1990-04-02 1992-05-12 Merrell Dow Pharmaceuticals Inc. Cyano esters and azepinones
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato
US5693636A (en) * 1991-06-28 1997-12-02 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
IT1255545B (it) * 1992-10-23 1995-11-09 Procedimento per la preparazione di diltiazem
CA2098446A1 (en) * 1992-09-30 1994-03-31 Eckard Weber 2,5-dihydro-2,5-dioxo-1h-azepines and 2,5-dihydro-2-oxo-1h-azepines and the use thereof as excitatory amino acid and glycine receptor antagonists
JPH09500134A (ja) * 1993-07-16 1997-01-07 メルク エンド カンパニー インコーポレーテッド ベンゾオキサジノンおよびベンゾピリミジノンピペリジニル早産防止オキシトシン受容体拮抗剤
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
JPH10503468A (ja) * 1994-03-24 1998-03-31 メリル・フアーマシユウテイカルズ・インコーポレイテツド 低コレステロール血性、抗アテローム性動脈硬化性および低トリグリセライド血性のメルカプトアセチルアミドジスルフィド誘導体
US5580867A (en) * 1994-09-09 1996-12-03 Universite De Montreal Myocardial protection during ischemia and reperfusion
ATE227717T1 (de) * 1996-12-10 2002-11-15 Abbott Lab 3-pyridylenantiomere und ihre verwendung als analgetika
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
US6472533B1 (en) 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
GB9907895D0 (en) * 1999-04-08 1999-06-02 Texas A & M Univ Sys Novel ligands for chiral catalysis
CN1298321C (zh) * 2002-04-19 2007-02-07 亚利桑那大学董事会 光损伤调控物在制备用于抑制由紫外线引起的光损伤的药物中的用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312691A (en) * 1963-08-23 1967-04-04 Ciba Geigy Corp 2, 3, 4, 5-tetrahydro-1-benzazepin-2-ones
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS59191036A (ja) * 1983-04-14 1984-10-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
GB2154577A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co 1,5-benzothiazepines
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
GB2154578A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co Novel 1,5-benzothiazepine derivatives and processes for preparing the same
GB2167063A (en) * 1984-11-17 1986-05-21 Tanabe Seiyaku Co 6 or 9-chloro-1, 5-benzothiazepine derivatives
CA1271747A (en) * 1985-06-12 1990-07-17 David M. Floyd Benzazepines derivatives
US4748239A (en) * 1985-06-12 1988-05-31 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1271748A (en) * 1985-12-12 1990-07-17 Jagabandhu Das Benzazepine derivatives
FR2597097B1 (fr) * 1986-04-15 1988-12-02 Synthelabo Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
ATE64925T1 (de) * 1986-08-20 1991-07-15 Mcneilab Inc Benzothiazepin-vasodilatoren mit aralkylsubstitution.
US4729994A (en) * 1986-08-20 1988-03-08 Mcneilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US4752645A (en) * 1986-10-09 1988-06-21 E. R. Squibb & Sons, Inc. Benzazepine derivatives
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones

Also Published As

Publication number Publication date
GB2231329A (en) 1990-11-14
IT8920933A0 (it) 1989-06-20
US4902684A (en) 1990-02-20
ES2016467A6 (es) 1990-11-01
PL162313B1 (pl) 1993-09-30
NO179449B (no) 1996-07-01
WO1989012633A1 (en) 1989-12-28
JPH04502002A (ja) 1992-04-09
IE64242B1 (en) 1995-07-26
IE891957L (en) 1989-12-20
GR890100410A (el) 1990-05-11
IT1230884B (it) 1991-11-08
IL90515A (en) 1994-07-31
NO905485D0 (no) 1990-12-19
JP2793674B2 (ja) 1998-09-03
IL90515A0 (en) 1990-01-18
GR1002099B (en) 1995-12-28
RU2090562C1 (ru) 1997-09-20
PT90914B (pt) 1994-12-30
CA1336975C (en) 1995-09-12
SE9004060L (sv) 1992-06-20
NO905485L (no) 1991-02-19
GB2231329B (en) 1992-10-21
FR2632953A1 (fr) 1989-12-22
HU210929B (en) 1995-09-28
KR920700207A (ko) 1992-02-19
CH681723A5 (xx) 1993-05-14
HU894298D0 (en) 1991-01-28
BE1003305A4 (fr) 1992-02-25
FI900813A0 (fi) 1990-02-19
AU614399B2 (en) 1991-08-29
FI94246C (fi) 1995-08-10
CN1027262C (zh) 1995-01-04
KR970002633B1 (en) 1997-03-06
SE9004060D0 (sv) 1990-12-19
ATA901089A (de) 1994-05-15
AT398567B (de) 1994-12-27
GB9002587D0 (en) 1990-08-29
AU3859389A (en) 1990-01-12
CN1039585A (zh) 1990-02-14
LU87865A1 (de) 1991-12-16
NL8920642A (nl) 1990-06-01
FR2632953B1 (fr) 1992-05-29
PT90914A (pt) 1989-12-29
NO179449C (no) 1996-10-09
NZ229612A (en) 1992-07-28
YU121389A (en) 1991-04-30
FI94246B (fi) 1995-04-28
HUT59908A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
EG19071A (en) Process for preparing of benzazepine and benzothiazepine derivatives
HU895305D0 (en) Process for the preparation of piperidinyl-benzimidazole derivatives
HUT52747A (en) Process for production of derivatives of cycloalcanon and/or cycloalcanol
HU896774D0 (en) Process for preparation of condensated-quinoline-derivatives
HU896728D0 (en) Process for preparation of mono-n-alkylated polyzamacrocyclides
HU895410D0 (en) Process for the preparation of quinolyl-oxazol-2-on derivatives
YU236989A (en) Derivatives of 2-iminobenzothiazoline and process for obtaining thereof
YU192989A (en) Process for preparing n-imidazolyl and n-imidazolyl-methyl derivatives of substituted bicyclical compounds
YU125389A (en) Process for preparing derivatives of tricyclical 3-oxo-propan-nitryl
ZA898741B (en) Use of azepinone derivatives
HU902101D0 (en) Process for producing derivatives of benzazepine and benzothiazepine
ZA90361B (en) Cephalosporin derivatives and processes for their preparation
ZA892089B (en) Cephalosporin derivatives and processes for their preparation
ZA905504B (en) Cephalosporin derivatives and processes for their preparation
HU900888D0 (en) Process for preparation of 1-arylsulfonyl-pyrrolidin-2-thion and 1-arylsulfonyl-piperidin-2-thion derivatives
YU135588A (en) Process for preparing derivatives of l-alanyl-l-proline
GR900100781A (en) Preparation process of selenophen derivatives
ZA894833B (en) Process for the preparation of homonojirimycin derivatives
PT85414A (en) Process for preparing cephalosporins and derivatives
ZA881990B (en) Dicyanoethylaryl derivatives and process for their preparation
PH27405A (en) Process for the preparation of substituted imidazolyl-alkyl-piperazine and diazepine derivatives
HU900159D0 (en) Process for preparation of tetrazide-derivatives
GB8830094D0 (en) Amidino-,imidazoline-,imidazolo-phenoxybenzyl and phyenlthiobenzyl derivatives and process for their preparation
YU140289A (en) Derivatives of cycloalkyl-thiazole and process for producing thereof
ZA894315B (en) Benzazepine and benzothiazepine derivatives